121 results
Page 2 of 7
8-K
EX-99.1
bj7jwtlp713ngng5ruk
7 Aug 23
Viatris Reports Strong Financial and Operational Results for Second Quarter 2023 and Return of Capital to Shareholders
7:38am
8-K
uu5 4lrzszbrhad
22 May 23
Coury will serve in this new role until the end of 2025
7:46am
8-K
EX-99.1
27w3ourkfli3q
8 May 23
Viatris Reports Strong Financial and Operational Results for First Quarter 2023 and Return of Capital to Shareholders
7:51am
8-K
EX-99.1
0sdwj0gz57b kb
29 Dec 22
Viatris Announces Appointments of Scott A. Smith and Elisha W. Finney
4:14pm
8-K
uozr5
29 Nov 22
Viatris Completes Biosimilars Transaction with Biocon Biologics
8:29am
SC TO-C
en36yy0hgb7ds6wu
14 Nov 22
Information about tender offer
8:09am
SC TO-C
EX-99.1
sfxhykxbjwsw6wz11zl7
14 Nov 22
Information about tender offer
8:09am
SC TO-C
EX-99.1
7nno76xq
8 Nov 22
Information about tender offer
6:06am
SC TO-C
npf36 k8w1mcux
8 Nov 22
Information about tender offer
6:06am
SC TO-C
e5jo3zj7c 8jiicikx5
7 Nov 22
Information about tender offer
5:26pm
SC TO-C
EX-99.2
yh3y645rlgz83a5
7 Nov 22
Information about tender offer
5:26pm
SC TO-C
EX-99.1
x10qfkyh
7 Nov 22
Information about tender offer
5:26pm
8-K
EX-99.1
7nt3p
7 Nov 22
Expects Biocon Biologics Transaction to Close Shortly
9:07am
8-K
EX-99.2
hoj1yk1lymg6ypc6
7 Nov 22
Expects Biocon Biologics Transaction to Close Shortly
9:07am
8-K
EX-99.1
d06aaeqirkryt78bs8qe
7 Nov 22
Viatris Reports Strong Third Quarter 2022 Results
7:41am